セフミノクス 化学特性,用途語,生産方法
効能
抗生物質, 細胞壁合成阻害薬
抗菌性
A semisynthetic cephamycin. Activity is similar to that of
cefoxitin and cefotetan, but the activity against enterobacteria
and B. fragilis is somewhat better . C. difficile
is inhibited by 4–16 mg/L. It is stable to the common
β-lactamases of enterobacteria and Bacteroides spp.
A 15-min intravenous infusion of 1 g achieves a serum concentration
of 30 mg/L after 1 h. The plasma half-life is c. 2 h
and around 68% is protein bound.
Its safety profile and uses are similar to those of other
cephamycins. It is available in Japan.
セフミノクス 上流と下流の製品情報
原材料
準備製品